相关实验视频
Updated: Jun 22, 2025
13:21
Graphene Coatings for Biomedical Implants
Published on: March 1, 2013
21.3K
纳米石墨烯凝块:一种新的纤维素基模仿静血材料
Tannaz Farrokhi1, Manos Gkikas1
1Department of Chemistry, University of Massachusetts Lowell, Lowell, Massachusetts 01854, United States.
ACS applied materials & interfaces
|July 1, 2024
概括
这项研究开发了一种基于氧化石墨烯 (GO) 的新型纳米材料,可以模仿纤维素原来有效地阻止内部出血. 合成血静止剂显示为创伤患者注射治疗的有希望,增强血液凝固,而不会引起有害的副作用.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 创伤医学 创伤医学
背景情况:
- 内出血是创伤患者的主要死亡原因,尤其是44岁以下的患者.
- 有效的止血剂是需要医护人员在医院前给药的.
- 目前的治疗方法在有效管理严重内出血方面面临挑战.
研究的目的:
- 开发和描述一种基于氧化石墨烯 (GO) 的新型PEGylated合成血静纳米材料.
- 通过使用功能化来模仿纤维素原在血液静止中的作用.
- 评估纳米材料在促进血小板聚合和血液凝结方面的有效性.
主要方法:
- 合成的PEG基化石墨烯氧化物 (GO-g-PEG) 纳米材料与纤维素原衍生 (GRGDS和H12) 功能化.
- 在封闭和动态流量条件下,在试验室中评估了富血小板血 (PRP) 聚合.
- 进行了全人血液凝固研究和血液溶解试验.
主要成果:
- GO-g-PEG-GRGDS和GO-g-PEG-H12显著增强了血小板聚合和PRP信号增强.
- 这些纳米材料表现出对激动剂依赖的静血活性,降低了自发凝结的风险.
- 血液溶解研究显示,红细胞溶解的最小程度 (<1%),凝血测试显示,与对照组相比,凝血更快,更明显.
结论:
- 纤维素基模拟PEGylated纳米基因显示出作为一种非溶血性,可注射的静血支架,用于内部出血的潜力.
- 该材料增强血小板聚合和凝固的能力对于其治疗应用至关重要.
- 进一步研究这种基于纳米基因的血静止剂可能会导致改善创伤护理干预措施.
相关概念视频
01:16Clot Retraction and Fibrinolysis
5.4K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.4K
01:09Coagulation
6.1K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
6.1K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
675
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
675